• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AICAR 通过激活 AMPK 减少 C57BL/6 小鼠的饮食诱导性脂肪肝。

AMPK activation by AICAR reduces diet induced fatty liver in C57BL/6 mice.

机构信息

Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalai Nagar, Tamil Nadu, India.

Department of Pathology, Karpaga Vinayaga Institute of Medical Sciences and Research Centre, Madhuranthagam, Tamil Nadu, India.

出版信息

Tissue Cell. 2023 Jun;82:102054. doi: 10.1016/j.tice.2023.102054. Epub 2023 Mar 2.

DOI:10.1016/j.tice.2023.102054
PMID:36913846
Abstract

Dysregulation of 5'-adenosine monophosphate-activated protein kinase (AMPK) occurs in metabolic disorders including non-alcoholic fatty liver disease (NAFLD) which makes it a molecular target for treatment. An AMPK activator, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) alleviates NAFLD in experimental rats, however the specific mechanism remains to be explored. We aimed to study the effect of AICAR on lipid levels, oxidant-antioxidant balance, AMPK and mTOR activation and FOXO3 gene expression in liver of mice model. Fatty liver was induced in two groups of C57BL/6 mice (groups 2 and 3) by providing a high fat high fructose diet (HFFD) for 10 weeks while groups 1 and 4 animals were fed normal pellet. For the last two weeks, groups 3 and 4 were administered AICAR (150 mg/kg bw/day, i.p.) while groups 1 and 2 were administered saline. AICAR decreased fatty liver, decreased glucose and insulin in circulation, prevented the accumulation of triglycerides and collagen and ameliorated oxidative stress in HFFD fed mice. At the molecular level, AICAR upregulated FOXO3 and p-AMPK expression and reduced p-mTOR expression. AMPK activation may involve FOXO3 in protection against NAFLD. The role of AMPK, mTOR and FOXO3 crosstalk in NAFLD needs to be characterised in future.

摘要

5'-腺苷单磷酸激活蛋白激酶(AMPK)的失调发生在代谢紊乱中,包括非酒精性脂肪性肝病(NAFLD),这使其成为治疗的分子靶点。AMPK 激活剂 5-氨基咪唑-4-甲酰胺-1-β-D-呋喃核糖苷(AICAR)可缓解实验大鼠的 NAFLD,但具体机制仍需探讨。我们旨在研究 AICAR 对高脂高果糖饮食(HFFD)喂养 10 周的 C57BL/6 小鼠模型肝脏中脂质水平、氧化还原平衡、AMPK 和 mTOR 激活以及 FOXO3 基因表达的影响。两组 C57BL/6 小鼠(第 2 组和第 3 组)通过提供高脂肪高果糖饮食(HFFD)10 周来诱导脂肪肝,而第 1 组和第 4 组动物则喂食正常颗粒饲料。在最后两周,第 3 组和第 4 组给予 AICAR(150mg/kg bw/day,ip),而第 1 组和第 2 组给予生理盐水。AICAR 可减少脂肪肝、降低循环中的葡萄糖和胰岛素、防止甘油三酯和胶原的积累,并改善 HFFD 喂养小鼠的氧化应激。在分子水平上,AICAR 上调 FOXO3 和 p-AMPK 的表达,并降低 p-mTOR 的表达。AMPK 激活可能涉及 FOXO3 在保护 NAFLD 中的作用。未来需要进一步研究 AMPK、mTOR 和 FOXO3 串扰在 NAFLD 中的作用。

相似文献

1
AMPK activation by AICAR reduces diet induced fatty liver in C57BL/6 mice.AICAR 通过激活 AMPK 减少 C57BL/6 小鼠的饮食诱导性脂肪肝。
Tissue Cell. 2023 Jun;82:102054. doi: 10.1016/j.tice.2023.102054. Epub 2023 Mar 2.
2
Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.康泰脂颗粒通过 AMPK/mTOR 信号通路减轻高脂饮食喂养大鼠和 HepG2 细胞的非酒精性脂肪肝病。
J Immunol Res. 2020 Aug 20;2020:3413186. doi: 10.1155/2020/3413186. eCollection 2020.
3
AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats.AICAR是一种AMPK激活剂,对大鼠酒精性脂肪肝具有保护作用。
Alcohol Clin Exp Res. 2005 Dec;29(12 Suppl):240S-5S. doi: 10.1097/01.alc.0000191126.11479.69.
4
The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN).腺苷一磷酸(AMP)类似物,5-氨基咪唑-4-羧酰胺核糖核苷酸(AICAR)可抑制高脂肪饮食下二乙基亚硝胺(DEN)处理的小鼠模型的肝脂肪变性和肝癌发生。
Med Sci Monit. 2018 Nov 26;24:8533-8543. doi: 10.12659/MSM.910544.
5
AICAR Ameliorates Non-Alcoholic Fatty Liver Disease via Modulation of the HGF/NF-κB/SNARK Signaling Pathway and Restores Mitochondrial and Endoplasmic Reticular Impairments in High-Fat Diet-Fed Rats.AICAR 通过调节 HGF/NF-κB/SNARK 信号通路改善非酒精性脂肪性肝病,并恢复高脂肪饮食喂养大鼠的线粒体和内质网损伤。
Int J Mol Sci. 2023 Feb 8;24(4):3367. doi: 10.3390/ijms24043367.
6
5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.5-氨基咪唑-4-甲酰胺-1-β-D-呋喃核糖苷(AICAR)对葡萄糖生成的影响,但不是能量代谢,在体内独立于肝 AMPK。
J Biol Chem. 2014 Feb 28;289(9):5950-9. doi: 10.1074/jbc.M113.528232. Epub 2014 Jan 8.
7
Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin.AMPK-FOXO3信号通路的激活通过上调硫氧还蛋白来减少脂肪酸诱导的细胞内活性氧增加。
Diabetes. 2009 Oct;58(10):2246-57. doi: 10.2337/db08-1512. Epub 2009 Jul 10.
8
ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK/mTOR mediated autophagy.载脂蛋白 E 缺乏通过阻碍 AMPK/mTOR 介导的自噬促进小鼠非酒精性脂肪性肝病。
Life Sci. 2020 Jul 1;252:117601. doi: 10.1016/j.lfs.2020.117601. Epub 2020 Apr 15.
9
Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NFB Signaling Pathway and Restores Gut Microbiota in High-Fat-Diet-Fed Mice.菊苣酸通过AMPK/Nrf2/NFB信号通路改善高脂饮食喂养小鼠的非酒精性脂肪性肝病并恢复肠道微生物群。
Oxid Med Cell Longev. 2020 Nov 3;2020:9734560. doi: 10.1155/2020/9734560. eCollection 2020.
10
Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice.牡荆素通过激活高脂肪饮食喂养小鼠的 AMPK 减轻非酒精性脂肪肝病。
Biochem Biophys Res Commun. 2019 Oct 29;519(1):106-112. doi: 10.1016/j.bbrc.2019.08.139. Epub 2019 Aug 29.

引用本文的文献

1
Lactiplantibacillus plantarum FRT4 protects against fatty liver hemorrhage syndrome: regulating gut microbiota and FoxO/TLR-4/NF-κB signaling pathway in laying hens.植物乳杆菌FRT4可预防脂肪肝出血综合征:调节蛋鸡肠道微生物群及FoxO/TLR-4/NF-κB信号通路
Microbiome. 2025 Mar 29;13(1):88. doi: 10.1186/s40168-025-02083-0.
2
AMPK agonist AICAR ameliorates maternal hepatic lipid metabolism disorder, inflammation, and fibrosis caused by PM exposure during pregnancy.AMPK激动剂AICAR可改善孕期暴露于颗粒物所致的母体肝脏脂质代谢紊乱、炎症及纤维化。
Sci Rep. 2025 Mar 13;15(1):8689. doi: 10.1038/s41598-025-93395-6.
3
Alterations in Glutathione Redox Homeostasis in Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review.
代谢功能障碍相关脂肪性肝病中谷胱甘肽氧化还原稳态的改变:一项系统评价
Antioxidants (Basel). 2024 Nov 28;13(12):1461. doi: 10.3390/antiox13121461.
4
Quantification of AICAR and study of metabolic markers after administration.AICAR的定量分析及给药后代谢标志物的研究。
RSC Adv. 2024 Jun 13;14(27):19001-19013. doi: 10.1039/d4ra02878c. eCollection 2024 Jun 12.
5
Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis.非酒精性脂肪性肝炎驱动的肝癌发生的生物标志物、分子靶点和机制的最新见解
Cancers (Basel). 2023 Sep 14;15(18):4566. doi: 10.3390/cancers15184566.
6
Metformin Induces Lipogenesis and Apoptosis in H4IIE Hepatocellular Carcinoma Cells.二甲双胍诱导H4IIE肝癌细胞的脂肪生成和凋亡。
Dev Reprod. 2023 Jun;27(2):77-89. doi: 10.12717/DR.2023.27.2.77. Epub 2023 Jun 30.